NCT03036345

Brief Summary

Surgery to the shoulder may be performed with patients seated upright in a position known as the "Beach Chair Position (BCP)." This position has certain advantages compared to alternative surgical positions (e.g. side lying) in some situations. However, it has been found that surgery in the BCP can temporarily decrease the amount of oxygen in the brain as a result of the combined effects of gravity and anaesthesia. This can result in complications following surgery such as some memory loss and confusion. Rarely, more serious complications have been reported in the past including death and stroke. Due to these reported complications the use of "cerebral oximetry" during shoulder surgery in the BCP has become more common. Before and during surgery, a monitor placed on the patients forehead measures the amount of oxygen present in the brain to help control this to an acceptable level. A number of monitors are now commercially available. Two monitors are commonly discussed in the literature; the INVOS™ 5100 and the FORE-SIGHT® machines. However, the actual relationship between the supply of oxygen to the brain during surgery and the chance of later developing problems with memory and thinking (known as "post operative cognitive decline" - POCD) is not clear. It is also not known if one monitor is more accurate than another at predicting these complications. Therefore, the main aim of this study is to examine the relationship between cerebral oxygen levels during shoulder surgery and the incidence of POCD (i.e. problems with memory and thinking). A second aim is to compare the INVOS™ 5100 and FORE-SIGHT® monitors ability to measure cerebral oxygen and cerebral desaturation events (CDEs) as well as the importance of other key clinical variables (e.g. blood pressure, nausea, body fat etc).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 29, 2016

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 30, 2017

Completed
4 months until next milestone

Study Start

First participant enrolled

May 25, 2017

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2020

Completed
Last Updated

January 16, 2019

Status Verified

January 1, 2019

Enrollment Period

2.5 years

First QC Date

December 29, 2016

Last Update Submit

January 14, 2019

Conditions

Outcome Measures

Primary Outcomes (20)

  • Trail making test: Delis-Kaplan Executive Function System

    The D-KEFs Trails subtest has four trials; visual scanning, number sequencing, letter sequencing and letter number sequencing.

    Baseline

  • Trail making test: Delis-Kaplan Executive Function System

    The D-KEFs Trails subtest has four trials; visual scanning, number sequencing, letter sequencing and letter number sequencing.

    1 day post-operative

  • Trail making test: Delis-Kaplan Executive Function System

    The D-KEFs Trails subtest has four trials; visual scanning, number sequencing, letter sequencing and letter number sequencing.

    8-14 days post-operative

  • Trail making test: Delis-Kaplan Executive Function System

    The D-KEFs Trails subtest has four trials; visual scanning, number sequencing, letter sequencing and letter number sequencing.

    6 weeks post-operative

  • Trail making test: Delis-Kaplan Executive Function System

    The D-KEFs Trails subtest has four trials; visual scanning, number sequencing, letter sequencing and letter number sequencing.

    3 months post-operative

  • Single letter verbal fluency

    This task requires the individual to spontaneously generate a list of words in 60 seconds, where the words cannot be name of places, people or other proper nouns.

    Baseline

  • Single letter verbal fluency

    This task requires the individual to spontaneously generate a list of words in 60 seconds, where the words cannot be name of places, people or other proper nouns.

    1 day post-operative

  • Single letter verbal fluency

    This task requires the individual to spontaneously generate a list of words in 60 seconds, where the words cannot be name of places, people or other proper nouns.

    8-14 days post-operative

  • Single letter verbal fluency

    This task requires the individual to spontaneously generate a list of words in 60 seconds, where the words cannot be name of places, people or other proper nouns.

    6 weeks post-operative

  • Single letter verbal fluency

    This task requires the individual to spontaneously generate a list of words in 60 seconds, where the words cannot be name of places, people or other proper nouns.

    3 months post-operative

  • Rey Auditory Verbal Learning Test

    The RAVLT assesses immediate and delayed auditory memory recall and recognition. The task consists of 15 nouns learned over 5 trials with a free recall after each presentation. The order of presentation remaining fixed across trials (List A). At the end of the 5th trial an interference list of 15 words is presented (List B), following a free recall of that list. Immediately after this, delayed recall of the first list is tested. Following a 20-minute delay, delayed recall and recognition of the first word list is assessed.

    Baseline

  • Rey Auditory Verbal Learning Test

    The RAVLT assesses immediate and delayed auditory memory recall and recognition. The task consists of 15 nouns learned over 5 trials with a free recall after each presentation. The order of presentation remaining fixed across trials (List A). At the end of the 5th trial an interference list of 15 words is presented (List B), following a free recall of that list. Immediately after this, delayed recall of the first list is tested. Following a 20-minute delay, delayed recall and recognition of the first word list is assessed.

    1 day post-operative

  • Rey Auditory Verbal Learning Test

    The RAVLT assesses immediate and delayed auditory memory recall and recognition. The task consists of 15 nouns learned over 5 trials with a free recall after each presentation. The order of presentation remaining fixed across trials (List A). At the end of the 5th trial an interference list of 15 words is presented (List B), following a free recall of that list. Immediately after this, delayed recall of the first list is tested. Following a 20-minute delay, delayed recall and recognition of the first word list is assessed.

    8-14 days post-operative

  • Rey Auditory Verbal Learning Test

    The RAVLT assesses immediate and delayed auditory memory recall and recognition. The task consists of 15 nouns learned over 5 trials with a free recall after each presentation. The order of presentation remaining fixed across trials (List A). At the end of the 5th trial an interference list of 15 words is presented (List B), following a free recall of that list. Immediately after this, delayed recall of the first list is tested. Following a 20-minute delay, delayed recall and recognition of the first word list is assessed.

    6 weeks post-operative

  • Rey Auditory Verbal Learning Test

    The RAVLT assesses immediate and delayed auditory memory recall and recognition. The task consists of 15 nouns learned over 5 trials with a free recall after each presentation. The order of presentation remaining fixed across trials (List A). At the end of the 5th trial an interference list of 15 words is presented (List B), following a free recall of that list. Immediately after this, delayed recall of the first list is tested. Following a 20-minute delay, delayed recall and recognition of the first word list is assessed.

    3 months post-operative

  • Letter-Number Sequencing (from Wechsler Adult Intelligence Scale, 4th edition)

    The examinee is verbally presented with a combination of numbers and letters or increasing amounts. The examinee is required to recall the numbers in ascending order then letters in alphabetical order.

    Baseline

  • Letter-Number Sequencing (from Wechsler Adult Intelligence Scale, 4th edition)

    The examinee is verbally presented with a combination of numbers and letters or increasing amounts. The examinee is required to recall the numbers in ascending order then letters in alphabetical order.

    1 day post-operative

  • Letter-Number Sequencing (from Wechsler Adult Intelligence Scale, 4th edition)

    The examinee is verbally presented with a combination of numbers and letters or increasing amounts. The examinee is required to recall the numbers in ascending order then letters in alphabetical order.

    8-14 days post-operative

  • Letter-Number Sequencing (from Wechsler Adult Intelligence Scale, 4th edition)

    The examinee is verbally presented with a combination of numbers and letters or increasing amounts. The examinee is required to recall the numbers in ascending order then letters in alphabetical order.

    6 weeks post-operative

  • Letter-Number Sequencing (from Wechsler Adult Intelligence Scale, 4th edition)

    The examinee is verbally presented with a combination of numbers and letters or increasing amounts. The examinee is required to recall the numbers in ascending order then letters in alphabetical order.

    3 months post-operative

Secondary Outcomes (12)

  • Cerebral desaturation events (INVOS)

    Intra-operative

  • Cerebral desaturation events (FORE-SIGHT)

    Intra-operative

  • Mean arterial pressure

    Intra-operative

  • Body Mass Index

    Baseline

  • Hypertension

    Baseline

  • +7 more secondary outcomes

Other Outcomes (3)

  • Depression Anxiety and Stress Scale-21

    Baseline, 1 day, 8-14 days, 6 weeks, 3 months

  • Social Relationships and Support Scale

    Baseline, 1 day, 8-14 days, 6 weeks, 3 months

  • Loneliness Scale

    Baseline, 1 day, 8-14 days, 6 weeks, 3 months

Study Arms (1)

Surgery patients

EXPERIMENTAL

Patients receiving shoulder surgery in the Beach Chair Position, and monitored by both INVOS and FORE-SIGHT monitors.

Device: Dual-monitoring

Interventions

Monitored using both INVOS and FORE-SIGHT monitors.

Surgery patients

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Receiving treatment primarily by, but not restricted to, one of the Primary investigators for a shoulder condition that requires surgery in the BCP.
  • Over 18 years of age
  • Able to read and speak English

You may not qualify if:

  • Under 18 years of age
  • Pregnant women
  • Pre-operative Mini-Mental State Examination (MMSE) \< 24
  • Pre-existing cerebrovascular disease as reported by the assessing medical consultant and recorded in patient charts
  • Orthostatic hypotension
  • American Society of Anaesthesiologists (ASA) physical status III, IV and V\*
  • History of drug and/or alcohol abuse
  • Neurological disease (e.g. previous stroke)
  • Significant mood and anxiety disorders as determined by treating consultant.
  • Any other condition, which in the opinion of the investigators, would render the patient unsuitable for participation in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brisbane Hand and Upper Limb Research Institute, Brisbane Private Hospital

Brisbane, Queensland, 4000, Australia

RECRUITING

Related Links

MeSH Terms

Conditions

Cognitive Dysfunction

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Study Officials

  • Mark Ross, MBBS

    Director

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 29, 2016

First Posted

January 30, 2017

Study Start

May 25, 2017

Primary Completion

December 1, 2019

Study Completion

June 1, 2020

Last Updated

January 16, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will share

Deidentified cerebral oximeter data acquisition files will be made available to the equipment manufacturers (Medtronic, CASMED) at the conclusion of the study.

Locations